Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003145955 | SCV003830360 | uncertain significance | Developmental and epileptic encephalopathy, 67 | 2021-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246129 | SCV004853259 | uncertain significance | Inborn genetic diseases | 2021-08-30 | criteria provided, single submitter | clinical testing | The c.935G>A (p.R312Q) alteration is located in exon 11 (coding exon 11) of the CUX2 gene. This alteration results from a G to A substitution at nucleotide position 935, causing the arginine (R) at amino acid position 312 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |